Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Medicine and Society Nov 2020 What Is Ethically Informed Risk Management? Alan J. Card, PhD, MPH, CPHQ, CPHRM Framing risk management goals as patient centered and evidence based helps align them with goals of ethics. AMA J Ethics. 2020;22(11):E965-975. doi: 10.1001/amajethics.2020.965. Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy." Podcast Jul 2023 Author Interview: “Fat Norms and the AMA” Jorie Braunold joins Ethics Talk to discuss her article: “Fat Norms and the AMA.” Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783. Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472. Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478. History of Medicine Jul 2023 Fat Norms and the AMA Jorie Braunold, MLIS In the early 20th century, the United States, as an industrialized nation with more food than ever, began to grapple with obesity. AMA J Ethics. 2023;25(7):E559-572. doi: 10.1001/amajethics.2023.559. Letter to the Editor Jun 2023 Response to “Science and Ethics of ‘Curing’ Misinformation” Jamaji C. Nwanaji-Enwerem, MD, PhD, MPP Trust is a social condition that positions science to beneficially contribute to democratic societies. AMA J Ethics. 2023;25(6):E458-460. doi: 10.1001/amajethics.2023.458. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.
Medicine and Society Nov 2020 What Is Ethically Informed Risk Management? Alan J. Card, PhD, MPH, CPHQ, CPHRM Framing risk management goals as patient centered and evidence based helps align them with goals of ethics. AMA J Ethics. 2020;22(11):E965-975. doi: 10.1001/amajethics.2020.965.
Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy."
Podcast Jul 2023 Author Interview: “Fat Norms and the AMA” Jorie Braunold joins Ethics Talk to discuss her article: “Fat Norms and the AMA.”
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.
Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472.
Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478.
History of Medicine Jul 2023 Fat Norms and the AMA Jorie Braunold, MLIS In the early 20th century, the United States, as an industrialized nation with more food than ever, began to grapple with obesity. AMA J Ethics. 2023;25(7):E559-572. doi: 10.1001/amajethics.2023.559.
Letter to the Editor Jun 2023 Response to “Science and Ethics of ‘Curing’ Misinformation” Jamaji C. Nwanaji-Enwerem, MD, PhD, MPP Trust is a social condition that positions science to beneficially contribute to democratic societies. AMA J Ethics. 2023;25(6):E458-460. doi: 10.1001/amajethics.2023.458.